Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
Androgen deprivation therapy is commonly used in combination with radiotherapy as part of the definitive treatment for men with clinically localized and locally advanced prostate cancer. Androgen deprivation has been associated with a wide range of iatrogenic effects impacting a variety of body sys...
Saved in:
Main Authors: | Matthew E. Johnson, Mark K. Buyyounouski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2012/580306 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
by: Katherine Neubecker, et al.
Published: (2017-01-01) -
An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
by: Kristene Myklak, et al.
Published: (2011-01-01) -
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
by: Lior Z. Braunstein, et al.
Published: (2014-01-01) -
The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer
by: Michael J. Smith, et al.
Published: (2012-01-01) -
Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study
by: Alexander R. Lucas, et al.
Published: (2025-02-01)